Wellgistics Health Completes Reverse Split
Rhea-AI Summary
Wellgistics Health (NASDAQ:WGRX) completed a 1-for-50 reverse stock split of its common shares, effective 12:01 a.m. ET on May 26, 2026. The stock now trades under a new CUSIP.
The split reduced outstanding common shares from about 125,671,251 to approximately 2,513,425 and is intended to raise the share price to help regain compliance with Nasdaq’s minimum bid price requirement. Fractional shares were rounded up to the nearest whole share.
AI-generated analysis. Not financial advice.
Positive
- Reverse split ratio of 1-for-50 completed on May 26, 2026
- Outstanding shares cut from about 125.7M to roughly 2.5M
- Action is intended to support regaining Nasdaq minimum bid price compliance
- Fractional shares from the split were rounded up to whole shares
Negative
- Company needs to regain compliance with Nasdaq minimum bid price rules
Key Figures
Market Reality Check
Peers on Argus
Only one peer, HKPD, appeared in momentum scans, moving up while WGRX was down 22.71% pre-news, pointing to stock-specific dynamics around the reverse split.
Previous Stock split Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 20 | Reverse stock split | Negative | -17.1% | Announcement and approval timing of 1-for-50 reverse split for Nasdaq compliance. |
Prior disclosure of this 1-for-50 reverse split was followed by a notably negative price reaction, suggesting investors previously treated the action bearishly.
Over recent weeks, Wellgistics released multiple updates around strategic deals, financings, and capital structure changes. On May 20, it announced the planned 1-for-50 reverse split to regain Nasdaq bid-price compliance, which coincided with a -17.05% move. That event fits into a broader pattern where structurally important but dilutive or risk-signaling news, including financings and strategic shifts, has been met with selling pressure.
Historical Comparison
In the past six months, Wellgistics disclosed one reverse split event tagged as “stock split,” which saw shares react negatively on that day. Today’s completion notice tracks the same capital-structure action already flagged to investors.
Stock-split news progressed from announcing the planned 1-for-50 reverse split on May 20 to confirming its legal effectiveness and new CUSIP on May 26, without changing the previously described mechanics.
Regulatory & Risk Context
An effective S-3 shelf filed on April 15, 2026 allows Wellgistics to offer up to $200,000,000 of various securities over time for general corporate purposes, giving the company significant flexibility to raise capital in the future.
Market Pulse Summary
This announcement confirms legal completion of Wellgistics’ 1-for-50 reverse stock split, reducing outstanding common shares to 2,513,425 and assigning a new CUSIP. The move targets Nasdaq minimum bid-price compliance rather than changing underlying operations. In context of prior communications about strategic transactions and capital needs, investors may monitor how the adjusted share structure interacts with the existing $200,000,000 shelf, future financings, and ongoing listing requirements.
Key Terms
reverse stock split financial
cusip regulatory
nasdaq capital market regulatory
minimum bid price requirement regulatory
AI-generated analysis. Not financial advice.
1-for-50 reverse split of common shares outstanding now complete
2,513,425 common shares now outstanding
A new CUSIP was issued in connection with reverse split
TAMPA, FL / ACCESS Newswire / May 26, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it completed a 1-for-50 reverse stock split (the "Reverse Split") of the Company's common stock, par value
The Reverse Split legally took effect at 12:01 a.m. Eastern Time, on May 26, 2026. The Reverse Split is intended to increase the per share trading price of the Common Stock to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
The 1-for-50 Reverse Split automatically converted every 50 previous shares of the Company's Common Stock into one share of Common Stock. No fractional shares were issued in connection with the Reverse Split. Any fractional share of Common Stock that would otherwise result from the Reverse Split was rounded up to the nearest whole share.
The Reverse Split reduced the number of shares of outstanding Common Stock from approximately 125,671,251 to approximately 2,513,425 shares of Common Stock.
About Wellgistics Health, Inc.
Wellgistics Health (NASDAQ:WGRX) is a Health IT leader integrating its proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects more than 6,500 pharmacies and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility verification, onboarding, adherence support, prior authorization, and cash-pay fulfillment designed to improve patient access and transparency across the prescription ecosystem.
For more information, visit www.wellgisticshealth.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the Company's intent or ability to regain compliance with Nasdaq's minimum bid price requirement, the expected effect of the reverse stock split on the per share trading price of the Company's common stock, and the Company's continued listing on The Nasdaq Capital Market. Forward-looking statements are based on current expectations, estimates and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks relating to fluctuations in the market price of the Company's common stock, the Company's ability to satisfy Nasdaq's continued listing requirements, market and trading conditions, the impact of the reverse stock split on investor interest and liquidity in the Company's common stock, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Wellgistics Media & Investor Contact
Media: media@wellgisticshealth.com
Investor Relations: IR@wellgisticshealth.com
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire